Anthropic rolls out health features, following OpenAI
Healthcare is turning out to be a key battleground as AI companies race to roll out new features in their quest to lure new users to their platforms.
Last week, OpenAI announced the launch of ChatGPT Health, in response to the 40 million health-related queries per day that the chatbot answers. The consumer-focused feature lets users connect health apps and upload medical records securely for the chatbot to analyze and explain.
Today Anthropic unveiled Claude for Healthcare, which offers similar features while also serving healthcare providers. The company described the new product as a “set of tools and resources that allow health care providers, payers, and consumers to use Claude for medical purposes through HIPAA-ready products.”
The company said the feature can be used by healthcare providers to speed up prior authorization requests, build stronger claims appeals, and coordinate patient care.
Patients can connect to systems to access their medical records and lab results, share health data securely from health apps, and “detect patterns” from health metrics.
Anthropic also expanded its existing Claude for Life Sciences product, enabling new connections to additional scientific platforms to support clinical trial management and regulatory work.
Today Anthropic unveiled Claude for Healthcare, which offers similar features while also serving healthcare providers. The company described the new product as a “set of tools and resources that allow health care providers, payers, and consumers to use Claude for medical purposes through HIPAA-ready products.”
The company said the feature can be used by healthcare providers to speed up prior authorization requests, build stronger claims appeals, and coordinate patient care.
Patients can connect to systems to access their medical records and lab results, share health data securely from health apps, and “detect patterns” from health metrics.
Anthropic also expanded its existing Claude for Life Sciences product, enabling new connections to additional scientific platforms to support clinical trial management and regulatory work.
